Xenon Pharmaceuticals
XENE
XENE
162 hedge funds and large institutions have $2.19B invested in Xenon Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.42% more ownership
Funds ownership: 96.58% → 97% (+0.42%)
7% less capital invested
Capital invested by funds: $2.37B → $2.19B (-$177M)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Holders
162
Holding in Top 10
8
Calls
$11.2M
Puts
$898K
Top Buyers
| 1 | +$23.3M | |
| 2 | +$21.1M | |
| 3 | +$19.9M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$13.1M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
+$10.8M |
Top Sellers
| 1 | -$37M | |
| 2 | -$24.1M | |
| 3 | -$13.4M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$12.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$10.5M |